Cargando…

Fused Deposition Modelling 3D-Printed Gastro-Retentive Floating Device for Propranolol Hcl Tablets

Three-dimensional printing has revolutionized drug manufacturing and has provided a solution to the limitations associated with the conventional manufacturing method by designing complex drug delivery systems with customized drug release profiles for personalized therapies. The present investigation...

Descripción completa

Detalles Bibliográficos
Autores principales: Alqahtani, Abdulsalam A., Mohammed, Abdul Aleem, Fatima, Farhat, Ahmed, Mohammed Muqtader
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10490505/
https://www.ncbi.nlm.nih.gov/pubmed/37688178
http://dx.doi.org/10.3390/polym15173554
_version_ 1785103855738945536
author Alqahtani, Abdulsalam A.
Mohammed, Abdul Aleem
Fatima, Farhat
Ahmed, Mohammed Muqtader
author_facet Alqahtani, Abdulsalam A.
Mohammed, Abdul Aleem
Fatima, Farhat
Ahmed, Mohammed Muqtader
author_sort Alqahtani, Abdulsalam A.
collection PubMed
description Three-dimensional printing has revolutionized drug manufacturing and has provided a solution to the limitations associated with the conventional manufacturing method by designing complex drug delivery systems with customized drug release profiles for personalized therapies. The present investigation aims to design a gastric floating tablet with prolonged gastric floating time and sustained drug release profile. In the present study, a gastro retentive floating device (GRFD) was designed and fabricated using a fused deposition modelling (FDM)-based 3D printing technique. This device acts as a multifunctional dosage form exhibiting prolonged gastric retention time and sustained drug release profile with improved oral bioavailability in the upper gastrointestinal tract. Commercial polyvinyl alcohol (PVA) and polylactic acid (PLA) filaments were used to design GRFD, which was comprised of dual compartments. The outer sealed compartment acts as an air-filled chamber that imparts buoyancy to the device and the inner compartment is filled with a commercial propranolol hydrochloride immediate-release tablet. The device is designed as a round-shaped shell with a central opening of varying size (1 mm, 2 mm, 3 mm, and 4 mm), which acts as a drug release window. Scanning electron microscope (SEM) images were used to determine morphological characterization. The in vitro buoyancy and drug release were evaluated using the USP type II dissolution apparatus. All the designed GRFDs exhibit good floating ability and sustained drug release profiles. GRFDs fabricated using PLA filament show maximum buoyancy (>24 h) and sustained drug release for up to 10 h. The floating ability and drug release from the developed devices were governed by the drug release window opening size and the filament material affinity towards the gastric fluid. The designed GRFDs show great prospects in modifying the drug release characteristics and could be applied to any conventional immediate-release product.
format Online
Article
Text
id pubmed-10490505
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104905052023-09-09 Fused Deposition Modelling 3D-Printed Gastro-Retentive Floating Device for Propranolol Hcl Tablets Alqahtani, Abdulsalam A. Mohammed, Abdul Aleem Fatima, Farhat Ahmed, Mohammed Muqtader Polymers (Basel) Article Three-dimensional printing has revolutionized drug manufacturing and has provided a solution to the limitations associated with the conventional manufacturing method by designing complex drug delivery systems with customized drug release profiles for personalized therapies. The present investigation aims to design a gastric floating tablet with prolonged gastric floating time and sustained drug release profile. In the present study, a gastro retentive floating device (GRFD) was designed and fabricated using a fused deposition modelling (FDM)-based 3D printing technique. This device acts as a multifunctional dosage form exhibiting prolonged gastric retention time and sustained drug release profile with improved oral bioavailability in the upper gastrointestinal tract. Commercial polyvinyl alcohol (PVA) and polylactic acid (PLA) filaments were used to design GRFD, which was comprised of dual compartments. The outer sealed compartment acts as an air-filled chamber that imparts buoyancy to the device and the inner compartment is filled with a commercial propranolol hydrochloride immediate-release tablet. The device is designed as a round-shaped shell with a central opening of varying size (1 mm, 2 mm, 3 mm, and 4 mm), which acts as a drug release window. Scanning electron microscope (SEM) images were used to determine morphological characterization. The in vitro buoyancy and drug release were evaluated using the USP type II dissolution apparatus. All the designed GRFDs exhibit good floating ability and sustained drug release profiles. GRFDs fabricated using PLA filament show maximum buoyancy (>24 h) and sustained drug release for up to 10 h. The floating ability and drug release from the developed devices were governed by the drug release window opening size and the filament material affinity towards the gastric fluid. The designed GRFDs show great prospects in modifying the drug release characteristics and could be applied to any conventional immediate-release product. MDPI 2023-08-26 /pmc/articles/PMC10490505/ /pubmed/37688178 http://dx.doi.org/10.3390/polym15173554 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alqahtani, Abdulsalam A.
Mohammed, Abdul Aleem
Fatima, Farhat
Ahmed, Mohammed Muqtader
Fused Deposition Modelling 3D-Printed Gastro-Retentive Floating Device for Propranolol Hcl Tablets
title Fused Deposition Modelling 3D-Printed Gastro-Retentive Floating Device for Propranolol Hcl Tablets
title_full Fused Deposition Modelling 3D-Printed Gastro-Retentive Floating Device for Propranolol Hcl Tablets
title_fullStr Fused Deposition Modelling 3D-Printed Gastro-Retentive Floating Device for Propranolol Hcl Tablets
title_full_unstemmed Fused Deposition Modelling 3D-Printed Gastro-Retentive Floating Device for Propranolol Hcl Tablets
title_short Fused Deposition Modelling 3D-Printed Gastro-Retentive Floating Device for Propranolol Hcl Tablets
title_sort fused deposition modelling 3d-printed gastro-retentive floating device for propranolol hcl tablets
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10490505/
https://www.ncbi.nlm.nih.gov/pubmed/37688178
http://dx.doi.org/10.3390/polym15173554
work_keys_str_mv AT alqahtaniabdulsalama fuseddepositionmodelling3dprintedgastroretentivefloatingdeviceforpropranololhcltablets
AT mohammedabdulaleem fuseddepositionmodelling3dprintedgastroretentivefloatingdeviceforpropranololhcltablets
AT fatimafarhat fuseddepositionmodelling3dprintedgastroretentivefloatingdeviceforpropranololhcltablets
AT ahmedmohammedmuqtader fuseddepositionmodelling3dprintedgastroretentivefloatingdeviceforpropranololhcltablets